Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:13 pm Purchase |
2021-12-31 | 13G | Profound Medical Corp. PROF |
Flynn James E | 1,713,797 8.250% |
673,376 (+64.72%) |
Filing History |
| 2022-02-11 4:13 pm Purchase |
2021-12-31 | 13G | Ignyte Acquisition Corp. IGNY |
Flynn James E | 725,000 9.950% |
725,000 (New Position) |
Filing History |
| 2022-02-11 4:12 pm Unchanged |
2021-12-31 | 13G | Orchard Therapeutics plc ORTX |
Flynn James E | 694,942 5.540% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:12 pm Sale |
2021-12-31 | 13G | Apria, Inc. APR |
Flynn James E | 1,655,795 4.670% |
-775,622 (-31.90%) |
Filing History |
| 2022-02-11 4:12 pm Purchase |
2021-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Flynn James E | 8,456,876 6.570% |
762,513 (+9.91%) |
Filing History |
| 2022-02-11 4:11 pm Sale |
2021-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI |
Flynn James E | 29,204 0.030% |
-9,500,796 (-99.69%) |
Filing History |
| 2022-02-11 4:11 pm Sale |
2021-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Flynn James E | 3,282,912 10.720% |
-166,000 (-4.81%) |
Filing History |
| 2022-02-11 4:11 pm Sale |
2021-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
Flynn James E | 958,125 3.470% |
-1,594,662 (-62.47%) |
Filing History |
| 2022-02-11 4:10 pm Purchase |
2021-12-31 | 13G | Pulmonx Corporation LUNG |
Flynn James E | 2,366,867 6.420% |
415,980 (+21.32%) |
Filing History |
| 2022-02-11 4:10 pm Sale |
2021-12-31 | 13G | IVERIC bio, Inc. ISEE |
Flynn James E | 4,761,138 4.150% |
-1,006,271 (-17.45%) |
Filing History |
| 2022-02-11 4:10 pm Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Flynn James E | 5,580,456 9.540% |
1,376,556 (+32.74%) |
Filing History |
| 2022-02-11 4:09 pm Unchanged |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Flynn James E | 10,000,000 8.060% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:09 pm Sale |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Flynn James E | 1,175,131 4.800% |
-630,906 (-34.93%) |
Filing History |
| 2022-02-11 4:08 pm Purchase |
2021-12-31 | 13G | AdaptHealth Corp. AHCO |
Flynn James E | 24,272,428 7.720% |
2,871,653 (+13.42%) |
Filing History |
| 2022-02-11 4:08 pm Purchase |
2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 4,695,020 9.910% |
2,159,519 (+85.17%) |
Filing History |
| 2022-02-08 1:33 pm Sale |
2021-12-31 | 13G | Brookdale Senior Living Inc. BKD |
Flynn James E | 4,274,808 2.310% |
-6,748,657 (-61.22%) |
Filing History |
| 2022-01-24 4:43 pm Purchase |
2022-01-13 | 13G | Silk Road Medical, Inc SILK |
Flynn James E | 1,861,917 5.340% |
1,861,917 (New Position) |
Filing History |
| 2021-12-07 5:19 pm Purchase |
2021-12-07 | 13G | Esperion Therapeutics, Inc. ESPR |
Flynn James E | 10,000,000 8.170% |
10,000,000 (New Position) |
Filing History |
| 2021-12-03 3:07 pm Purchase |
2021-11-29 | 13G | Kura Oncology, Inc. KURA |
Flynn James E | 3,513,756 5.280% |
3,513,756 (New Position) |
Filing History |
| 2021-11-19 5:19 pm Purchase |
2021-11-12 | 13D | DFP Healthcare Acquisitions Corp. DFPH |
Flynn James E | 24,074,650 4.900% |
13,614,650 (+130.16%) |
Filing History |